Your browser doesn't support javascript.
loading
Thalamocortical control of propofol phase-amplitude coupling.
Soplata, Austin E; McCarthy, Michelle M; Sherfey, Jason; Lee, Shane; Purdon, Patrick L; Brown, Emery N; Kopell, Nancy.
Affiliation
  • Soplata AE; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts, United States of America.
  • McCarthy MM; Department of Mathematics & Statistics, Boston University, Boston, Massachusetts, United States of America.
  • Sherfey J; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts, United States of America.
  • Lee S; Department of Neuroscience, Brown University, Providence, Rhode Island, United States of America.
  • Purdon PL; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Brown EN; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Kopell N; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
PLoS Comput Biol ; 13(12): e1005879, 2017 12.
Article in En | MEDLINE | ID: mdl-29227992
ABSTRACT
The anesthetic propofol elicits many different spectral properties on the EEG, including alpha oscillations (8-12 Hz), Slow Wave Oscillations (SWO, 0.1-1.5 Hz), and dose-dependent phase-amplitude coupling (PAC) between alpha and SWO. Propofol is known to increase GABAA inhibition and decrease H-current strength, but how it generates these rhythms and their interactions is still unknown. To investigate both generation of the alpha rhythm and its PAC to SWO, we simulate a Hodgkin-Huxley network model of a hyperpolarized thalamus and corticothalamic inputs. We find, for the first time, that the model thalamic network is capable of independently generating the sustained alpha seen in propofol, which may then be relayed to cortex and expressed on the EEG. This dose-dependent sustained alpha critically relies on propofol GABAA potentiation to alter the intrinsic spindling mechanisms of the thalamus. Furthermore, the H-current conductance and background excitation of these thalamic cells must be within specific ranges to exhibit any intrinsic oscillations, including sustained alpha. We also find that, under corticothalamic SWO UP and DOWN states, thalamocortical output can exhibit maximum alpha power at either the peak or trough of this SWO; this implies the thalamus may be the source of propofol-induced PAC. Hyperpolarization level is the main determinant of whether the thalamus exhibits trough-max PAC, which is associated with lower propofol dose, or peak-max PAC, associated with higher dose. These findings suggest the thalamus generates a novel rhythm under GABAA potentiation such as under propofol, its hyperpolarization may determine whether a patient experiences trough-max or peak-max PAC, and the thalamus is a critical component of propofol-induced cortical spectral phenomena. Changes to the thalamus may be a critical part of how propofol accomplishes its effects, including unconsciousness.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalamus / Propofol Type of study: Prognostic_studies Limits: Aged / Humans Language: En Journal: PLoS Comput Biol Journal subject: BIOLOGIA / INFORMATICA MEDICA Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalamus / Propofol Type of study: Prognostic_studies Limits: Aged / Humans Language: En Journal: PLoS Comput Biol Journal subject: BIOLOGIA / INFORMATICA MEDICA Year: 2017 Document type: Article Affiliation country: